-
Posted: May 24th, 2019, 2:00am GMT
Conditions: Plexiform Neurofibroma; Neurofibromatosis Type 1 (NF1)
Interventions: Drug: Mirdametinib (PD-0325901) oral capsule or dispersible tablet
Sponsors: SpringWorks Therapeutics, Inc.
Active, not recruiting
-
Posted: May 16th, 2019, 2:00am GMT
Conditions: Glioma; Gliomas; High Grade Glioma; Malignant Glioma; Low Grade Glioma
Interventions: Device: 3T MRI scanner
Sponsors: National Cancer Institute (NCI)
Recruiting
-
Posted: May 14th, 2019, 2:00am GMT
Conditions: Low-grade Glioma
Interventions: Device: ReMind iPad app; Device: Healthy SMS texting; Behavioral: In-person cognitive rehabilitation; Behavioral: Telehealth cognitive rehabilitation
Sponsors: University of California, San Francisco; Tilburg University; University of California, Berkeley
Active, not recruiting
-
Posted: May 14th, 2019, 2:00am GMT
Conditions: Intracranial Venous Pressures
Interventions: Procedure: Venogram
Sponsors: Wake Forest University Health Sciences
Recruiting
-
Posted: May 8th, 2019, 2:00am GMT
Conditions: Breast Cancer
Sponsors: Chinese University of Hong Kong; Department of Electronic and computer engineering, HKUST; Department of clinical oncology, CUHK; Department of Anatomical and Cellular Pathology,PWH; Department of Surgery, North District Hospital
Recruiting
-
Posted: May 7th, 2019, 2:00am GMT
Conditions: Type2 Diabetes; Myocardial Infarction; Ischemic Stroke; Cardiovascular Death; Heart Failure; All-Cause Mortality
Interventions: Drug: Sodium-glucose cotransporter 2 (SGLT2) inhibitors; Drug: Dipeptidyl peptidase-4 (DPP-4) inhibitors
Sponsors: Canadian Network for Observational Drug Effect Studies, CNODES; Drug Safety and Effectiveness Network, Canada; Canadian Institutes of Health Research (CIHR)
Completed
-
Posted: May 3rd, 2019, 2:00am GMT
Conditions: Breast Cancer; DCIS; LCIS
Interventions: Radiation: MRIdian Radiation Treatment Unit
Sponsors: University of Wisconsin, Madison
Suspended
-
Posted: May 3rd, 2019, 2:00am GMT
Conditions: Solid Tumor, Childhood; Lymphoma; Brain Tumor, Pediatric
Interventions: Drug: BMS-986158; Drug: BMS-986378
Sponsors: Dana-Farber Cancer Institute; Stand Up To Cancer
Active, not recruiting
-
Posted: May 2nd, 2019, 2:00am GMT
Conditions: Glioma
Interventions: Device: Cereset Research Wearable; Procedure: Stress management therapy; Other: Questionnaire administration; Other: Quality of Life Assessment
Sponsors: Wake Forest University Health Sciences
Withdrawn